0000899243-21-025422.txt : 20210622 0000899243-21-025422.hdr.sgml : 20210622 20210622201053 ACCESSION NUMBER: 0000899243-21-025422 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210619 FILED AS OF DATE: 20210622 DATE AS OF CHANGE: 20210622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Golumbeski George CENTRAL INDEX KEY: 0001586660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 211036919 MAIL ADDRESS: STREET 1: C/O CELGENE CORP. STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1018 W. 11TH STREET CITY: AUSTIN STATE: TX ZIP: 78703 BUSINESS PHONE: 919-864-2700 MAIL ADDRESS: STREET 1: 1018 W. 11TH STREET CITY: AUSTIN STATE: TX ZIP: 78703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-19 0 0001680367 Shattuck Labs, Inc. STTK 0001586660 Golumbeski George C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 1 0 0 0 Stock Option (Right to Buy) 29.34 2021-06-19 4 A 0 3434 0.00 A 2031-06-19 Common Stock 3434 3434 D This option represents a right to purchase a total of 3,434 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. /s/ Erin Ator Thomson, Attorney-in-Fact for George Golumbeski 2021-06-22